Navigation Links
Pharsight Uses FDA Disease Model to Support Oncology Drug Development
Date:11/20/2007

y Decisions: Data/models of Diseases, Drugs, Placebo, Baseline, and Dropouts." Additional information can be found at http://www.diahome.org or requested from FDA at pharmacometrics@fda.hhs.gov.

"As outlined in FDA's Critical Path Initiative, model-based drug development offers an important approach to improving drug development knowledge management and decision-making," said Shawn O'Connor, president, chief executive officer, and chairman of Pharsight. "We are pleased that FDA has shared their NSCLC survival model with the public to describe prior knowledge in this area. With our unmatched collective modeling expertise, Pharsight scientists are uniquely positioned to help our clients build, adapt, and extend drug-disease models in their own development programs. Over the past three years, we have supported more than 30 oncology programs and modeling initiatives for industry clients, from pre-clinical to Phase III and covering critical issues in trial design, dose selection, and development strategy. We look forward to collaborating with our client to share feedback with FDA, and to contributing to ongoing industry discussions on opportunities for sharing drug-disease models to support quantitative decision-making in clinical development."

About Pharsight Corporation

Pharsight Corporation develops and markets integrated products and services that enable pharmaceutical and biotechnology companies to achieve significant and enduring improvements in the development and use of therapeutic products. Pharsight's goal is to help customers reduce the time, cost and risk of drug development, as well as optimize the post-approval marketing and use of pharmaceutical products.

Pharsight's approach enhances the fundamental element of drug development success: strong decision-making. By adopting the Pharsight approach, customers acquire a new decision-making process with the potential to systematically imp
'/>"/>

SOURCE Pharsight Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
2. Kosans Motilin Receptor Agonist, Licensed to Pfizer, Enters Phase 1 Clinical Trial in Gastroesophageal Reflux Disease
3. Avicena Scientific Collaborator Advances Program for Using Energy Enhancing Molecules to Treat Neuromuscular Diseases
4. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
5. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
6. Baxter and The Alzheimers Disease Cooperative Study Group to Pursue a Phase III Study of Gammagard Liquid in Patients With Alzheimers Disease
7. Four Analyses of Three-Year Clinical Data Suggest CYPHER(R) Sirolimus-Eluting Coronary Stent May Provide Alternative to Surgery for Patients with Multivessel Disease
8. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
9. Public Forum to Discuss Addiction as a Treatable Disease and Highlight National Alcohol and Drug Addiction Recovery Month
10. K-State Researchers Bringing Expertise to Kansas City Symposium on Disease and National Security
11. Genta Initiates First Clinical Trial with New Oral Drug (G4544) to Treat Bone Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... , June 19, 2013   Life ... announces a licensing agreement granting Suzhou Ribo Life ... manufacture siRNA therapeutics in China ... will formulate proprietary siRNA molecules in combination with ... to address human diseases with high unmet medical ...
(Date:6/19/2013)... , 19. Juni 2013 /PRNewswire/ ... dass mit der Entwicklung von SCS ... Schritt in der Beschichtung mit Parylene ... Vorteile von biokompatiblem Parylene mit antimikrobiellen ... Beseitigung schädlicher Mikroorganismen auf beschichteten medizinischen ...
(Date:6/18/2013)... -- Intercept Pharmaceuticals, Inc.  (NASDAQ: ICPT ), a ... commercialization of novel bile acid therapeutics to treat chronic ... public offering of 1,730,000 shares of its common stock ... In addition, Intercept has granted the underwriters a 30-day ... of common stock. All of the shares ...
Breaking Medicine Technology:Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 2Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 3Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 4Specialty Coating Systems gibt die Einführung einer neuen antimikrobiellen Parylene-Technologie bekannt 2Intercept Pharmaceuticals Announces Pricing of Public Offering of Common Stock 2
(Date:6/19/2013)... (PRWEB) June 19, 2013 Fit Body ... Laing recently held a charity boot camp in order to ... The fitness boot camp franchise hosted the Brent ... 11 a.m. with 75 boot camp participants and collected over ... boot camp marks the second fundraiser held for Orlando local ...
(Date:6/19/2013)... North American Seminars combines a ... with an online continuing education course directed ... therapists. , The two day live ... online continuing education course will provide ... skills needed to evaluate and treat dizziness and ...
(Date:6/19/2013)... 19, 2013 Blueforce Development Corporation, ... machine software, today announced it has been awarded ... Fusion Engine technology. The award coincides with ... of key strategic partnerships. , Blueforce Development ... and machine-to-machine (M2M) software products that support the ...
(Date:6/19/2013)... June 19, 2013 The reason for the ... because users can place a 4x8 flood tray inside the ... to work around. In addition, Gorilla Grow Tents are ... are the tallest, thickest and strongest grow tents on the ... grow tent standards. , Gorilla Grow Tents are ...
(Date:6/19/2013)... Tornadoes and their devastating aftermath have increased ... fallen victim to these deadly storms find it hard ... protected families and corporations from natural and man-made disasters ... in the philosophy of providing a storm shelter that ... people to stand up, with light and a battery-operated ...
Breaking Medicine News(10 mins):Health News:Fit Body Boot Camp in Orlando Held Successful “Brent Can Breathe” Charity Boot Camp with Proceeds Going to Support Orlando Local Brent Snyder with Cystic Fibrosis 2Health News:New Evidence Based Information on Treatment for Over 8 Million People in the U.S. Affected With Disorders of the Vestibular System 2Health News:Blueforce Awarded Patent for Decentralized Sensor Fusion 2Health News:Stealth Grow Tent Brand’s Popularity Rises 2Health News:Radius Engineering International Inc. Tornado-Resistant Storm Shelters 2
... spread of lung infections, including pandemic strains , , FRIDAY, Jan. ... dampen part of the body,s immune response so infections can ... person to perish, a new study says. , The compound ... mice, helped mitigate the cytokine response, a common immune reaction ...
... FRANCISCO, Calif., Jan. 23 Rigel,Pharmaceuticals, Inc. (Nasdaq: RIGL ... conference on Multiple Sclerosis taking,place this week in Santa Fe, New ... 25, 2009 , Time: 2:30 - ... Therapeutic Approaches to MS , Presentation ...
... source of information on scleroderma and the financial help available for ... ... 2009 -- NeedyMeds, a national nonprofit, adds a new resource page ... scleroderma-specific source of help for those looking for information on the ...
... enters the future and endures the tough economy through the guidance of ... attended annual convention hosted by the SPCP. This year the convention and ... ... Des Plaines, IL (PRWEB) January 23, 2009 -- Permanent Makeup enters the ...
... highlight the dangers of infection from live birds, report ... peanut butter contaminated with salmonella has dominated the headlines ... is also prevalent in live poultry. , The Jan. ... and Prevention,s Morbidity and Mortality Weekly Report ...
... DIEGO, Jan. 22 SeQual Technologies Inc., a ... worldwide for their reliability, quality, and revolutionary design ... Release (AWR) from the U.S. Army,s Research, Development, ... 1000A. The certification indicates that the Eclipse(R) Oxygen ...
Cached Medicine News:Health News:Drug Impedes Body's Deadly Reaction to Flu Virus 2Health News:New Source of Information on Scleroderma Medications 2Health News:New Source of Information on Scleroderma Medications 3Health News:Society of Permanent Cosmetic Professionals (SPCP) Hosts 18th Annual Convention in Las Vegas 2Health News:Society of Permanent Cosmetic Professionals (SPCP) Hosts 18th Annual Convention in Las Vegas 3Health News:Society of Permanent Cosmetic Professionals (SPCP) Hosts 18th Annual Convention in Las Vegas 4Health News:Salmonella Common In U.S. Poultry 2Health News:Salmonella Common In U.S. Poultry 3Health News:SeQual Technologies is Awarded the U.S. Army Airworthiness Certification 2
Fenestrated 14 mm blades. Wide extension of blade for protection of lids. Self-locking mechanism. Dull finish....
Solid 16 mm blades. Self-locking mechanism. Dull finish....
Infant model. Blades: 7 mm. Solid blades with locking mechanism. Dull finish....
Fenestrated 16 mm blades. Self-locking mechanism. Dull finish....
Medicine Products: